Mineralocorticoid receptor antagonists
- First Online:
- Cite this article as:
- Parthasarathy, H.K. & MacDonald, T.M. Current Science Inc (2007) 9: 45. doi:10.1007/s11906-007-0009-3
- 101 Views
With an increasingly aging population, the need for effective treatment of cardiovascular diseases (eg, heart failure, hypertension, and ischemic heart disease) cannot be overemphasized. The vital importance of mineralocorticoid receptor antagonists for treating cardiovascular conditions has only been appreciated in the last decade. The re-emergence of mineralocorticoid receptor antagonists has provided clinicians with an important tool towards complete blockade of the reninangiotensin-aldosterone axis.